OKRA Technologies becomes Veeva partner to drive AI into life science decision-making
OKRA Technologies has become a Veeva Technology Partner, meaning its artificial intelligence-driven analytics for life sciences will be made available to customers of the cloud computing software giant.
St John’s Innovation Centre-based OKRA will integrate its platform with Veeva CRM Suggestions to give commercial teams explainable and actionable insights.
The move provides further access and exposure to OKRA, which is already working with three of the world’s top 10 pharmaceutical companies.
At $22billion, Veeva, headquartered in California, has a similar market cap to Twitter. Founded in 2007 by Peter Gassner, it works with 600 life science companies and has spent three years in the Fortune 100 Fastest-Growing Companies list - this year at number 14.
Dr Loubna Bouarfa, founder and CEO of OKRA Technologies, who won CEO of the Year at the Cambridge Independent Science and Technology Awards 2019, said: “Our goal is to empower strategic and operational teams across life sciences to take action.
“The integrated solution will aim to support commercial teams across the business to take decisions with all the evidence and information they need, whilst also providing the reasons behind its recommendations.
“Providing AI solutions that place the user at the centre and enable individuals to execute their vision through explainable AI is our primary objective.”
OKRA’s platform helps life science teams make decisions and deliver the right drug to the right patient by delivering suggestions, predictions and explanations using AI.
Its engine takes in real-world data - structured, unstructured, clinical, commercial and scientific literature - to drive its insights.
The company said its integration with Veeva CRM Suggestions will help support the “optimal prescribing of drugs to patients” in different countries.
Founded in 2016 and with an additional office in Leiden. In the Netherlands, OKRA was a finalist in the AI Company of the Year category at the Cambridge Independent Science and Technology Awards 2019.
More by this authorPaul Brackley